Our results showed a significant increase in the number of 53BP1 foci in dihydrotanshinone I-treated HCC cells at the concentrations of 2.5 and 5.0 μM, respectively (Figs. 2A, 2B). The gene discussed is TP53BP1; the disease is hepatocellular carcinoma.